Dalfampridine Tablet, Film Coated, Extended Release
Product Images NDC 63629-9450

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dalfampridine (NDC 63629-9450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dalfampridine-equa (Dalfampridine Equa)

Dalfampridine-equa (Dalfampridine Equa)
This appears to be a formula to calculate the estimated glomerular filtration rate (eGFR) using the Cockcroft-Gault equation. The equation involves subtracting the age from 140, then multiplying the result by the person's weight in kilograms. The serum creatinine value (in mg/dL) is then multiplied by 72. The final result is the estimated creatinine clearance (CrCl) in mL/min.*
FDA Label Image

Dalfampridine-figure1 (Dalfampridine Figure1)

FDA Label Image

Dalfampridine-figure2 (Dalfampridine Figure2)

Dalfampridine-figure2 (Dalfampridine Figure2)
This is a chart that shows the results of a study comparing a medication called Dalfampridine Extended-release Tablets to a placebo. The study looked at the percent increase in walking speed from a baseline measurement for both groups. The chart shows the percentage of patients in each group who experienced a certain level of improvement in walking speed. The results show that overall, patients taking the medication experienced a greater increase in walking speed compared to those taking the placebo. There are also p-values provided to show statistical significance between the two groups at each threshold.*
FDA Label Image

Dalfampridine-struc (Dalfampridine Struc)

FDA Label Image

Label (Lbl636299450)

Label (Lbl636299450)
This is a prescription medication called Dalfampridine Extended-release Tablets. Each tablet contains 10 mg of the medicine. The dosage information is present in the package insert. The tablets should not be crushed, chewed or dissolved, and should be taken whole. The medicine should be stored between 15°C to 30° C (59°F to 86° F). The NDC number of this medication is 63629-9450-01. Dispense in containers with child-resistant closures and include the accompanying medication guide with each patient's prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.